Entera Bio Ltd. insider trading
Every open-market purchase and sale by Entera Bio Ltd.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $140,880 8 trades by 5 insiders
3 months later: median −12.6% (−19.9% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Entera Bio Ltd.’s insiders pay?
From January 18, 2022 to March 11, 2026, 13 insiders reported 27 open-market purchases and 0 sales not made under a pre-set plan in Entera Bio Ltd.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Ellis Sean | Director | 6 | — | — | 0 | — | March 9, 2026 |
| Toledano Miranda Jayne | Chief Executive Officer | 5 | — | — | 0 | — | December 30, 2025 |
| Lieberman Gerald M | Director | 4 | — | — | 0 | — | December 27, 2023 |
| Germano Geno J | Director | 2 | — | — | 0 | — | March 11, 2026 |
| Taitel Haya | Director | 2 | — | — | 0 | — | February 11, 2026 |
| Jamas Spiros | Chief Executive Officer | 1 | — | — | 0 | — | January 24, 2022 |
| Malca Yonatan | Director | 1 | — | — | 0 | — | January 18, 2022 |
| Mayron Ron | Director | 1 | — | — | 0 | — | January 19, 2022 |
| Ostrov Gerald M | Director | 1 | — | — | 0 | — | January 25, 2022 |
| Ratan Ramesh | U.S.based CFO | 1 | — | — | 0 | — | January 24, 2022 |
| Rubin Steven D | Director | 1 | — | — | 0 | — | February 11, 2026 |
| Schwartz Phillip | President of R&D | 1 | — | — | 0 | — | January 24, 2022 |
| Yaacov-Garbeli Dana | Chief Financial Officer | 1 | — | — | 0 | — | November 15, 2022 |